Nadia Minopoli

Via S. Pansini 5
Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

TRPML1 agonists synergize with enzyme replacement therapy in fibroblasts from Pompe disease patients.

TRPML1 agonists synergize with enzyme replacement therapy in fibroblasts from Pompe disease patients.

Journal: Journal of translational medicine

Published: March 10, 2026

C-Branched Iminosugars as Selective Pharmacological Chaperones of Lysosomal α-Glucosidase for the Treatment of Pompe Disease.

C-Branched Iminosugars as Selective Pharmacological Chaperones of Lysosomal α-Glucosidase for the Treatment of Pompe Disease.

Journal: Journal of medicinal chemistry

Published: September 15, 2025

GMPPB-CDG Results in Lysosomal Dysfunction and Acid Alpha-Glucosidase Deficiency.

GMPPB-CDG Results in Lysosomal Dysfunction and Acid Alpha-Glucosidase Deficiency.

Journal: Journal of inherited metabolic disease

Published: September 12, 2025

Loss of the batten disease protein CLN3 leads to mis-trafficking of M6PR and defective autophagic-lysosomal reformation.

Loss of the batten disease protein CLN3 leads to mis-trafficking of M6PR and defective autophagic-lysosomal reformation.

Journal: Nature communications

Published: March 03, 2022

Carnitine is a pharmacological allosteric chaperone of the human lysosomal α-glucosidase.

Carnitine is a pharmacological allosteric chaperone of the human lysosomal α-glucosidase.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: September 27, 2021

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease.

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease.

Journal: EMBO molecular medicine

Published: April 15, 2021

Pathogenesis of Mucopolysaccharidoses, an Update.

Pathogenesis of Mucopolysaccharidoses, an Update.

Journal: International journal of molecular sciences

Published: March 05, 2020

microRNAs as biomarkers in Pompe disease.

microRNAs as biomarkers in Pompe disease.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: February 06, 2018

Showing 1-8 of 8

Last Updated: 09/26/2026